AVatar MedTech develops an innovative set of medical devices that standardizes a surgical method for reconstructing aortic and pulmonary valves in both children and adults using autologous tissue. Specifically designed with pediatric patients in mind, these devices make the procedure simpler, faster and easily reproducible by any cardiac surgeon, while enhancing patient safety. The beneficiaries of AVatar MedTech include patients with semilunar valvular diseases who receive life-changing or life-saving surgeries, as well as cardiovascular surgeons who gain access to tools that simplify complex procedures, eliminating the need for in-depth understanding of valve geometry, mathematics and hydrodynamic laws.
Tomás Armendariz is a young entrepreneur with a profound passion for business, particularly in the health industry. Tomás has immense experience in strategic consulting, project management and financial analysis, which has honed his ability to solve complex business problems and bring innovative solutions to market. This drive led Tomás to found AVatar MedTech. He is committed to a mission that truly matters — enhancing and, in critical cases, saving the lives of patients with cardiovascular diseases. As CEO, Tomás is deeply inspired by the positive impact his work has on both children and adults, which fuels his commitment to excellence and progress.